Accuray Unveils New Company Website Reflecting Industry-Leading Patient-First Cancer Treatment Innovation and Care
Summary
Accuray Incorporated (Nasdaq: ARAY) announced today the unveiling of a new corporate website that reflects the companys evolution and leadership in patient-first cancer treatment innovations. The fully redesigned, modern site puts critical disease and treatment information at the fingertips of website visitors, highlights the unique features and capabilities that set the companys radiotherapy tools-including the CyberKnife®, TomoTherapy® and Radixact® Systems-apart, and will serve as home base for details on future breakthroughs. "We hope youll take a moment to check out the new accuray.com and explore the enhanced features and functionality designed to better serve our customers, our community and everyone involved in a patients cancer care journey. "We believe our CyberKnife, TomoTherapy and Radixact Systems have each, individually, changed the game in radiation therapy by enabling physicians to deliver precise, non-invasive treatment options while minimizing side effects and helping improve quality of life for countless patients across the globe," said Lionel Hadjadjeba, M.D., Senior Vice President and Chief Commercial Officer at Accuray. Built to complement http://www.accuray.com and designed specifically for cancer patients, these two sites deliver additional resources and information about the disease and potential treatment options.